Loading company…
ID 402093042 · FY 2020–2024 · 5 years
კომპანიის ძირითად საქმიანობას წარმოადგენს ერთჯერადი მოხმარების სამედიცინო საქოლნის, სამედიცინო ხელსაწყოების და სამედიცინო აპარატურის რეალიზაცია, ასევე სერვისული მომსახურების გაწევა.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 34.5% | 34.3% | 22.3% | 16.6% | 33.1% |
| EBITDA Margin | 14.1% | 24.9% | 10.8% | 10.4% | 23.3% |
| EBITDAR | 373 | 2,249 | 778 | 1,202 | 2,409 |
| EBITDAR Margin | 14.9% | 25.1% | 11.1% | 10.6% | 23.6% |
| EBIT Margin | 14.1% | 24.9% | 10.8% | 10.4% | 23.3% |
| Net Profit Margin | 17.5% | 23.1% | 6.1% | 9.6% | 18.2% |
| Operating Expense % of Sales | 20.4% | 9.4% | 11.5% | 6.2% | 9.8% |
| Returns | |||||
| Return on Assets (ROA) | 51.3% | 42.9% | 34.8% | 17.3% | 28.4% |
| Return on Equity (ROE) | 77.9% | 106.1% | 40.6% | 75.3% | 184.3% |
| ROIC [EBIT / Invested Capital] | 67.7% | 159.9% | 146.0% | 157.7% | N/A |
| Leverage & liquidity | |||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 65.9% | 40.4% | 85.7% | 22.9% | 15.4% |
| Net Debt | -40 | -555 | -540 | -694 | -2,815 |
| Cash & Equivalents | 40 | 555 | 540 | 694 | 2,815 |
| Total Debt | N/A | N/A | N/A | N/A | N/A |
| Efficiency & working capital | |||||
| Inventory Turnover | 35.02x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 10.4 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 3.26x | 2.13x | 13.81x | 2.10x | 2.92x |
| Days Sales Outstanding (DSO) | 111.9 | 171.3 | 26.4 | 173.9 | 125.2 |
| Payables Turnover | 5.62x | 2.05x | 30.79x | 187.68x | 1.24x |
| Days Payable Outstanding (DPO) | 65.0 | 178.4 | 11.9 | 1.9 | 293.6 |
| Cash Conversion Cycle | 57.3 days | -7.1 days | 14.6 days | 172.0 days | -168.5 days |
| Asset Turnover | 2.93x | 1.86x | 5.67x | 1.80x | 1.56x |
| Cash flow & dividends | |||||
| Operating Cash Flow | 3,781 | 9,043 | 6,737 | 10,481 | 12,414 |
| Free Cash Flow (OCF − Capex proxy) | -362 | 675 | 312 | 121 | 12,392 |
| Cash Conversion (OCF / EBITDA) | 1067.3% | 406.1% | 889.9% | 892.9% | 521.5% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).